CHIP-ping away at tau

Journal of Clinical Investigation

Volumn 117, Issue 3, 2007, Pages 590-592

  Goryunov, Dmitry ^a   Liem, Ronald K H ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EC 102; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 INTERACTING PROTEIN; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DOWN SYNDROME; HUMAN; MUTATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW;

ANIMALS; BRAIN DISEASES; CHROMOSOMES, HUMAN, PAIR 17; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; PROTEIN FOLDING; TAU PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 33847364935     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31505     Document Type: Review

References (18)

1. Young, J.C., Barral, J.M., and Ulrich Hartl, F. 2003. More than folding: localized functions of cytosolic chaperones. Trends Biochem. Sci. 28:541-547.
2. Ardley, H.C., and Robinson, P.A. 2004. The role of ubiquitin-protein ligases in neurodegenerative disease. Neurodegener. Dis. 1:71-87.
3. Muchowski, P.J., and Wacker, J.L. 2005. Modulation of neurodegeneration by molecular chaperones. Nat. Rev. Neurosci. 6:11-22.
4. Dou, F., et al. 2003. Chaperones increase association of tau protein with microtubules. Proc. Natl. Acad. Sci. U. S. A. 100:721-726.
5. Ardley, H.C., et al. 2003. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin. Mol. Biol. Cell. 14:4541-4556.
6. Ballinger, C.A., et al. 1999. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19:4535-4545.
7. Connell, P., et al. 2001. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 3:93-96.
8. Young, J.C., Moarefi, I., and Hartl, F.U. 2001. Hsp90: a specialized but essential protein-folding tool. J. Cell Biol. 154:267-273.
9. Murata, S., Minami, Y., Minami, M., Chiba, T., and Tanaka, K. 2001. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2:1133-1138.
10. Petrucelli, L., et al. 2004. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13:703-714.
11. Shimura, H., Schwartz, D., Gygi, S.P., and Kosik, K.S. 2004. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279:4869-4876.
12. Sahara, N., et al. 2005. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 94:1254-1263.
13. Dickey, C.A., et al. 2006. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho-and caspase-3-cleaved tau species. J. Neurosci. 26:6985-6996.
14. Dickey, C.A., et al. 2007. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117:648-658. doi:10.1172/JCI29715.
15. Biamonte, M.A., et al. 2006. Orally active purine-based inhibitors of the heat shock protein 90. J. Med. Chem. 49:817-828.
16. Dickey, C.A., et al. 2006. HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J. 20:753-755.
17. Panaretou, B., et al. 1998. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17:4829-4836.
18. Gong, C.X., Liu, F., Grundke-Iqbal, I., and Iqbal, K. 2005. Post-translational modifications of tau protein in Alzheimer's disease. J. Neural Transm. 112:813-838.